Patents by Inventor Scott M. Connors

Scott M. Connors has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method and dosage regimens for eliminating a chemical substance in blood
    Patent number: 9211268
    Abstract: A method of reducing the concentration of a chemical or drug substance in the blood plasma comprising titrating an initial peak concentration of the chemical or drug substance in the blood for a predefined dosing period, titrating a lowest concentration level of the chemical or drug substance in the blood immediately before the end of the dosing period, and providing a plurality of subsequent dosing periods where each subsequent dosing period requires administration of a dosing amount of the chemical or drug substance and titrating of the peak concentration and the lowest concentration level to ensure that the lowest concentration level of the chemical or drug substance in the blood plasma for the subsequent dosing period is decreased by not more than five percent of the lowest concentration level of the previous dosing period and where the plurality of dosing periods added together is seventy days or more.
    Type: Grant
    Filed: March 23, 2012
    Date of Patent: December 15, 2015
    Inventors: Kenneth C. Slater, Brenda E. Richardson, Scott M. Connors, Wei-wei Chang
  • DRUG DETOXIFICATION PROTOCOL USING MICRODOSING
    Publication number: 20140100241
    Abstract: This invention relates to use of an opioid receptor agonist in microdose quantities to reduce or eliminate the withdrawal symptoms associated with discontinuing drug use. The dosage of the agonist is reduced over an extended period of time.
    Type: Application
    Filed: September 27, 2013
    Publication date: April 10, 2014
    Inventors: Kenneth C. Slater, Brenda E. Richardson, Scott M. Connors
  • Method and dosage regimens for eliminating a chemical substance in blood
    Publication number: 20120208835
    Abstract: A method of reducing the concentration of a chemical or drug substance in the blood plasma comprising titrating an initial peak concentration of the chemical or drug substance in the blood for a predefined dosing period, titrating a lowest concentration level of the chemical or drug substance in the blood immediately before the end of the dosing period, and providing a plurality of subsequent dosing periods where each subsequent dosing period requires administration of a dosing amount of the chemical or drug substance and titrating of the peak concentration and the lowest concentration level to ensure that the lowest concentration level of the chemical or drug substance in the blood plasma for the subsequent dosing period is decreased by not more than five percent of the lowest concentration level of the previous dosing period and where the plurality of dosing periods added together is seventy days or more.
    Type: Application
    Filed: March 23, 2012
    Publication date: August 16, 2012
    Inventors: Kenneth C. Slater, Brenda E. Richardson, Scott M. Connors, Wei-wei Chang
  • Method and dosage regimens for eliminating a chemical substance in blood
    Patent number: 8163731
    Abstract: A method of reducing the concentration of a chemical or drug substance in the blood plasma that targets the same or similar receptors as the normal neurotransmitters in the central or peripheral nervous system includes titrating an initial peak concentration of the chemical or drug substance in the blood for a predefined dosing period, titrating a lowest concentration level of the chemical or drug substance in the blood immediately before the end of the dosing period, and providing a plurality of subsequent dosing periods where each subsequent dosing period requires administration of a dosing amount of the chemical or drug substance and titrating of the peak concentration and the lowest concentration level to ensure that the lowest concentration level of the chemical or drug substance in the blood plasma for the subsequent dosing period is decreased by not more than five percent of the lowest concentration level of the previous dosing period and where the plurality of dosing periods added together extends the
    Type: Grant
    Filed: August 20, 2008
    Date of Patent: April 24, 2012
    Assignee: Rhodes Technologies
    Inventors: Kenneth C. Slater, Brenda E. Richardson, Scott M. Connors, Wei-wei Chang
  • Method and dosage regimens for eliminating a chemical substance in blood
    Publication number: 20100048535
    Abstract: A method of reducing the concentration of a chemical or drug substance in the blood plasma that targets the same or similar receptors as the normal neurotransmitters in the central or peripheral nervous system includes titrating an initial peak concentration of the chemical or drug substance in the blood for a predefined dosing period, titrating a lowest concentration level of the chemical or drug substance in the blood immediately before the end of the dosing period, and providing a plurality of subsequent dosing periods where each subsequent dosing period requires administration of a dosing amount of the chemical or drug substance and titrating of the peak concentration and the lowest concentration level to ensure that the lowest concentration level of the chemical or drug substance in the blood plasma for the subsequent dosing period is decreased by not more than five percent of the lowest concentration level of the previous dosing period and where the plurality of dosing periods added together extends the
    Type: Application
    Filed: August 20, 2008
    Publication date: February 25, 2010
    Inventors: Kenneth C. Slater, Brenda E. Richardson, Scott M. Connors, Wei-wei Chang